The PTPN22 C1858T gene variant is associated with proinsulin in new-onset type 1 diabetes

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Nielsen, Lotte B ^a   Pörksen, Sven ^a   Andersen, Marie Louise M ^a   Fredheim, Siri ^a   Svensson, Jannet ^a   Hougaard, Philip ^b   Vanelli, Maurizio ^c   Åman, Jan ^d   Mortensen, Henrik B ^a   Hansen, Lars ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSITY OF PARMA   (Italy)

^d ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C PEPTIDE; GLUTAMATE DECARBOXYLASE ANTIBODY; HEMOGLOBIN A1C; INSULIN; INSULIN ANTIBODY; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PANCREAS ISLET CELL ANTIBODY; PROINSULIN; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE RELATED IA 2 MOLECULE; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER 8 ANTIBODY; PTPN22 PROTEIN, HUMAN;

ALLELE; ARTICLE; CHILD; DIABETIC KETOACIDOSIS; DISEASE COURSE; FEMALE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PANCREAS ISLET BETA CELL; PRESCHOOL CHILD; SCHOOL CHILD; BLOOD; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC PREDISPOSITION; GENETICS; REGRESSION ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TIME;

AUTOANTIBODIES; C-PEPTIDE; CHILD; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROINSULIN; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; REGRESSION ANALYSIS; TIME FACTORS;

EID: 79953105627     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-41     Document Type: Article

References (20)

1. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-78. 10.1038/nature05911, 2719288, 17554300, Wellcome Trust Case Control Consortium.
2. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, Bailey R, Nejentsev S, Field SF, Payne F, Lowe CE, Szeszko JS, Hafler JP, Zeitels L, Yang JH, Vella A, Nutland S, Stevens HE, Schuilenburg H, Coleman G, Maisuria M, Meadows W, Smink LJ, Healy B, Burren OS, Lam AA, Ovington NR, Allen J, Adlem E, Leung HT, Wallace C, Howson JM, Guja C, Ionescu-Tîrgovişte C, , Simmonds MJ, Heward JM, Gough SC, , Dunger DB, Wicker LS, Clayton DG. Genetics of Type 1 Diabetes in Finland, Wellcome Trust Case Control Consortium Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007, 39:857-864. 10.1038/ng2068, 2492393, 17554260, Genetics of Type 1 Diabetes in Finland, Wellcome Trust Case Control Consortium.
3. Nielsen LB, Mortensen HB, Chiarelli F, Holl R, Swift P, de Beaufort C, Pociot F, Hougaard P, Gammeltoft S, Knip M, Hansen L, . Hvidoere Study Group Impact of IDDM2 on disease pathogenesis and progression in children with newly diagnosed type 1 diabetes: reduced insulin antibody titres and preserved beta cell function. Diabetologia 2006, 49:71-74. 10.1007/s00125-005-0042-1, 16307231, Hvidoere Study Group.
4. Pörksen S, Nielsen LB, Mortensen HB, Danne T, Kocova M, Castaño L, Pociot F, Hougaard P, Ekstrøm CT, Gammeltoft S, Knip M, Hansen L, . Hvidøre Study Group on Childhood Diabetes Variation within the PPARG gene is associated with residual beta-cell function and glycemic control in children and adolescents during the first year of clinical type 1 diabetes. Pediatr Diabetes 2008, 9:297-302. Hvidøre Study Group on Childhood Diabetes.
5. Nielsen LB, Ploug KB, Swift P, Ørskov C, Jansen-Olesen I, Chiarelli F, Holst JJ, Hougaard P, Pörksen S, Holl R, Beaufort C, Gammeltoft S, Rorsman P, Mortensen HB, Hansen L, . on behalf of the Hvidøre Study Group Co-localization of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes. European Journal of Endocrinology 2007, 156:663-671. 10.1530/EJE-06-0756, 17535866, on behalf of the Hvidøre Study Group.
6. Petrone A, Spoletini M, Zampetti S, Capizzi M, Zavarella S, Osborn J, Pozzilli P, Buzzetti R, . Immunotherapy Diabetes (IMDIAB) Group The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control. Diabetes Care 2008, 31:1214-1218. 10.2337/dc07-1158, 18252906, Immunotherapy Diabetes (IMDIAB) Group.
7. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M, Eisenbarth GS, Comings D, Mustelin T. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004, 36:337-338. 10.1038/ng1323, 15004560.
8. Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM, Vella A, Nutland S, Rance HE, Maier L, Barratt BJ, Guja C, Ionescu-Tîrgoviste C, Savage DA, Dunger DB, Widmer B, Strachan DP, Ring SM, Walker N, Clayton DG, Twells RC, Gough SC, Todd JA. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 2004, 53:3020-3023. 10.2337/diabetes.53.11.3020, 15504986.
9. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM, Conn MT, Chang M, Chang SY, Saiki RK, Catanese JJ, Leong DU, Garcia VE, McAllister LB, Jeffery DA, Lee AT, Batliwalla F, Remmers E, Criswell LA, Seldin MF, Kastner DL, Amos CI, Sninsky JJ, Gregersen PK. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004, 75:330-337. 10.1086/422827, 1216068, 15208781.
10. Kyogoku C, Langefeld CD, Ortmann WA, Lee A, Selby S, Carlton VE, Chang M, Ramos P, Baechler EC, Batliwalla FM, Novitzke J, Williams AH, Gillett C, Rodine P, Graham RR, Ardlie KG, Gaffney PM, Moser KL, Petri M, Begovich AB, Gregersen PK, Behrens TW. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004, 75:504-507. 10.1086/423790, 1182029, 15273934.
11. Velaga MR, Wilson V, Jennings CE, Owen CJ, Herington S, Donaldson PT, Ball SG, James RA, Quinton R, Perros P, Pearce SH. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 2004, 89:5862-5865. 10.1210/jc.2004-1108, 15531553.
12. Chelala C, Duchatelet S, Joffret ML, Bergholdt R, Dubois-Laforgue D, Ghandil P, Pociot F, Caillat-Zucman S, Timsit J, Julier C. PTPN22 R620W functional variant in type 1 diabetes and autoimmunity related traits. Diabetes 2007, 56:522-526. 10.2337/db06-0942, 17259401.
13. Mortensen HB, Hougaard P, Swift P, Hansen L, Holl RW, Hoey H, Bjoerndalen H, de Beaufort C, Chiarelli F, Danne T, Schoenle EJ, Aman J, . on behalf of the Hvidoere Study Group on Childhood Diabetes New Definition for the Partial Remission Period in Children and Adolescents with T1D. Diabetes Care 2009, 32:1384-1390. 10.2337/dc08-1987, 2713624, 19435955, on behalf of the Hvidoere Study Group on Childhood Diabetes.
14. Mortensen HB, Swift PG, Holl RW, Hougaard P, Hansen L, Bjoerndalen H, de Beaufort CE, Knip M, . Hvidoere Study Group on Childhood Diabetes Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis. Pediatr Diabetes 2010, 11:218-226. 10.1111/j.1399-5448.2009.00566.x, 19708904, Hvidoere Study Group on Childhood Diabetes.
15. Vaziri-Sani F, Oak S, Radtke J, Lernmark A, Lynch K, Agardh CD, Cilio CM, Lethagen AL, Ortqvist E, Landin-Olsson M, Törn C, Hampe CS. ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset. Autoimmunity 2010,
16. Bottini N, Vang T, Cucca F, Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol 2006, 18:207-213. 10.1016/j.smim.2006.03.008, 16697661.
17. Truyen I, De Pauw P, Jørgensen PN, Van Schravendijk C, Ubani O, Decochez K, Vandemeulebroucke E, Weets I, Mao R, Pipeleers DG, Gorus FK, . Belgian Diabetes Registry Proinsulin levels and the proinsulin:c-peptide ratio complement autoantibody measurement for predicting type 1 diabetes. Diabetologia 2005, 48:2322-9. 10.1007/s00125-005-1959-0, 16211374, Belgian Diabetes Registry.
18. Røder ME, Porte D, Schwartz RS, Kahn SE. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998, 83:604-608.
19. Snorgaard O, Kjems LL, Røder ME, Hartling SG, Dinesen B, Binder C. Proinsulin immunoreactivity in recent-onset IDDM: the significance of insulin antibodies and insulin autoantibodies. Diabetes Care 1996, 19:146-150. 10.2337/diacare.19.2.146, 8718435.
20. Kawasaki E, Matsuura N, Eguchi K. Type 1 diabetes in Japan. Diabetologia 2006, 49:828-36. 10.1007/s00125-006-0213-8, 16568259.